Is OPKO Health Inc (OPK) stock a good long term investment?
Find the latest OPKO Health, Inc. (OPK) stock quote, history, news and other vital information to help you with your stock trading and investing.
How much does OPKO Health make a year?
Mar 28, 2022 · Opko Health Inc () Stock Market info Recommendations: Buy or sell Opko Health stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Opko Health share forecasts, stock quote and buy / sell signals below.According to present data Opko Health's OPK shares and potentially its market environment have been in bearish cycle last 12 …
What kind of company is op OPKO?
OPKO Health (OPK) Outpaces Stock Market Gains: What You Should Know OPKO Health (OPK) closed the most recent trading day at $3.51, moving …
What does OPKO Health's P/E ratio mean?
Mar 08, 2022 · Opko Health Inc. (OPK) stock is trading at $3.11 as of 11:08 AM on Tuesday, Mar 8, a drop of -$0.01, or -0.32% from the previous closing price of $3.12. The stock has traded between $2.98 and $3.13 so far today. Volume today is low. So far 1,049,366 shares have traded compared to average volume of 5,209,219 shares. More About Opko Health Inc.
Is OPKO Health a good stock to buy?
There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" OPKO Health stock.
Will OPKO Health stock go up?
Stock Price Forecast The 4 analysts offering 12-month price forecasts for OPKO Health Inc have a median target of 6.75, with a high estimate of 8.50 and a low estimate of 5.50. The median estimate represents a +102.10% increase from the last price of 3.34.
What does OPKO Health do?
A Diverse Healthcare Company Focused on Improving Patient Lives. At OPKO Health, we seek to serve unmet patient needs through our first in class products, comprehensive diagnostics laboratories, robust research and development pipeline, and unique pharmaceutical business solutions.
Who owns OPKO Health company?
Dr. Phillip FrostAt OPKO Health, the entrepreneurial acumen of our founder and CEO, Dr. Phillip Frost, has led to the development of a diverse healthcare company flexible enough to adapt to evolving patient needs.
Is OPK a buy or sell?
According to the issued ratings of 3 analysts in the last year, the consensus rating for OPKO Health stock is Buy based on the current 1 hold rating and 2 buy ratings for OPK.
Is OPK a good stock to buy 2022?
Is OPKO HEALTH Stock a good buy in 2022, according to Wall Street analysts? The consensus among 2 Wall Street analysts covering (NASDAQ: OPK) stock is to Buy OPK stock.
What industry is OPKO Health?
healthcare companyOPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally.
Who is the CEO of OPKO Health?
Phillip Frost (Mar 2007–)OPKO Health / CEOPhillip Frost is an American entrepreneur. Wikipedia
When did OPKO Health go public?
The Company expects its common stock will begin trading on the NASDAQ Global Select Market (“NASDAQ”) on June 24, 2016, and its shares will continue to trade under the ticker symbol “OPK.”Jun 13, 2016
"Should I invest in Opko Health stock?" "Should I trade "OPK" stock today?"
According to our live Forecast System, Opko Health Inc stock is a not so good long-term (1-year) i...
What is the Opko Health stock price / share price today?
The Opko Health stock price is 3.720 USD today.
Will Opko Health stock price grow / rise / go up?
Yes. The OPK stock price can go up from 3.720 USD to 3.813 USD in...
Is it profitable to invest in Opko Health stock?
Yes. The long-term earning potential is + 2.50 % in one year.
Will OPK stock price fall / drop?
No. See above .
What will Opko Health stock price be worth in five years (2027)?
The OPK ("OPK" ) future stock price will be 6.643 USD .
Will OPK stock price crash?
According to our analysis, this will not happen.
Will Opko Health stock price hit 10 USD price in a year?
Not within a year. See above .
Will Opko Health stock price hit 20 USD price in a year?
Not within a year. See above .
Is OPKO Health a buy right now?
What stocks does MarketBeat like better than OPKO Health?
2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for OPKO Health in the last twelve months. There are currently 2 buy ratings for the stock.
When is OPKO Health's next earnings date?
Wall Street analysts have given OPKO Health a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but OPKO Health wasn't one of them.
How were OPKO Health's earnings last quarter?
OPKO Health is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.#N#View our earnings forecast for OPKO Health.
How has OPKO Health's stock price been impacted by Coronavirus?
OPKO Health, Inc. (NASDAQ:OPK) issued its quarterly earnings data on Thursday, July, 29th. The biotechnology company reported ($0.03) EPS for the quarter, missing the consensus estimate of $0.02 by $0.05. The biotechnology company had revenue of $442.40 million for the quarter, compared to analysts' expectations of $457.57 million.
What price target have analysts set for OPK?
OPKO Health's stock was trading at $1.69 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, OPK stock has increased by 110.7% and is now trading at $3.56.#N#View which stocks have been most impacted by COVID-19.
What is Philip Frost's approval rating as OPKO Health's CEO?
2 brokerages have issued 12 month price objectives for OPKO Health's shares. Their forecasts range from $6.00 to $7.00. On average, they anticipate OPKO Health's share price to reach $6.50 in the next year.
OPKO Health's (OPK) Arm Boosts Prenatal Screening With Buyout
21 employees have rated OPKO Health CEO Philip Frost on Glassdoor.com. Philip Frost has an approval rating of 16% among OPKO Health's employees. This puts Philip Frost in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.
OPKO Health's, Inc. (NASDAQ:OPK) CEO is on a Buying Spree Before the US Drug Approval Decision
OPKO Health's (OPK) BioReference's acquisition to expand its NIPS offerings and thereby enhance prenatal screening.
Midday Market Update: Why Are Stocks Down Today?
OPKO Health, Inc. (NASDAQ:OPK) a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. Their CEO has been continuously buying shares, and we were curious as to why that might be.
OPKO Health's (OPK) Q2 Earnings Lag Estimates, Margins Down
The stock market isn’t doing so hot on Friday as market worries continue to weigh on investors in our midday update. Source: Shutterstock There’s no getting around the fact that fears of the delta variant of the novel coronavirus are spreading. In addition to that, investors also have concerns when it comes to inflation and the rest of the market.
Opko Health (OPK) Q2 2021 Earnings Call Transcript
OPKO Health's (OPK) second-quarter results benefit from strength in both its reportable segments.
OPKO Health (OPK) Reports Q2 Loss, Misses Revenue Estimates
Image source: The Motley Fool. Opko Health (NASDAQ: OPK)Q2 2021 Earnings CallJul 29, 2021, 4:30 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood afternoon, ladies and gentlemen, and welcome to the OPKO Health second-quarter 2021 financial results conference call.
Earnings Preview: OPKO Health (OPK) Q2 Earnings Expected to Decline
OPKO Health (OPK) delivered earnings and revenue surprises of -250.00% and -3.31%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Is Opko stock up?
OPKO Health (OPK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Who is Taylor Carmichael?
OPKO's stock is up 9% in 2020, while the broader market is down by a double-digit percentage. OPKO's subsidiary, BioReference Labs, is one of the major diagnostic outfits running tests for COVID-19 in the U.S. So investors are starting to feel optimistic about the company again.
Business
Risks
- 2 equities research analysts have issued 1-year target prices for Opko Health's stock. Their predictions range from $5.00 to $20.00. On average, they anticipate Opko Health's share price to reach $12.50 in the next year. This suggests a possible upside of 489.6% from the stock's current price. View Analyst Price Targets for Opko Health.
Ratings
- 2 Wall Street analysts have issued \"buy,\" \"hold,\" and \"sell\" ratings for Opko Health in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of \"Buy.\" View Analyst Ratings for Opko Health.
Reception
- Headlines about OPK stock have trended neutral this week, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Opko Health e…
Ownership
- Opko Health's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (4.90%), Dimensional Fund Advisors LP (0.70%), Wells Fargo & Company MN (0.24%), RK Asset Management LLC (0.19%), Fosun International Ltd (0.14%) and Pictet Asset Management Ltd. (0.11%). Company insiders that own Opko Health stock include A…
Operations
- Opko Health has a market capitalization of $1.31 billion and generates $990.30 million in revenue each year. The biotechnology company earns $-153,040,000.00 in net income (profit) each year or ($0.25) on an earnings per share basis. Opko Health employs 5,690 workers across the globe.
Access
- Opko Health's mailing address is 4400 BISCAYNE BLVD., MIAMI FL, 33137. The biotechnology company can be reached via phone at 305-575-4100 or via email at [email protected].